A detailed history of University Of Wisconsin Foundation transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, University Of Wisconsin Foundation holds 289,201 shares of RNA stock, worth $20.5 Million. This represents 10.67% of its overall portfolio holdings.

Number of Shares
289,201
Holding current value
$20.5 Million
% of portfolio
10.67%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$28.46 - $50.36 $8.23 Million - $14.6 Million
289,201 New
289,201 $12.6 Billion

Others Institutions Holding RNA

About Avidity Biosciences, Inc.


  • Ticker RNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,127,000
  • Market Cap $3.69B
  • Description
  • Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...
More about RNA
Track This Portfolio

Track University Of Wisconsin Foundation Portfolio

Follow University Of Wisconsin Foundation and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of University Of Wisconsin Foundation, based on Form 13F filings with the SEC.

News

Stay updated on University Of Wisconsin Foundation with notifications on news.